The study to examine the appropriate skin dose in intensity modulated radiotherapy with cetuximab

Trial Profile

The study to examine the appropriate skin dose in intensity modulated radiotherapy with cetuximab

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 13 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top